IL-6 R alpha

IL-6 R alpha 분자 정보

영어 이름Interleukin-6 receptor alpha subunit시판 약물 수8
임상 약물 수9표적 별명IL6RA,IL6RQ,IL6Q,Interleukin-6 Receptor alpha Subunit,sIL6R,gp80,IL-6R subunit alpha,Membrane glycoprotein 80,IL6R,Interleukin 6 Receptor,IL-6 Receptor Subunit Alpha,CD126 Antigen,IL-6R 1,IL-6RA,Interleukin-6 Receptor Subunit Alpha,IL-6R-Alpha,IL-6R-1,CD126
최고 연구 개발 단계Approved
영어 이름Interleukin-6 receptor alpha subunit
표적 별명IL6RA,IL6RQ,IL6Q,Interleukin-6 Receptor alpha Subunit,sIL6R,gp80,IL-6R subunit alpha,Membrane glycoprotein 80,IL6R,Interleukin 6 Receptor,IL-6 Receptor Subunit Alpha,CD126 Antigen,IL-6R 1,IL-6RA,Interleukin-6 Receptor Subunit Alpha,IL-6R-Alpha,IL-6R-1,CD126
시판 약물 수8
임상 약물 수9
최고 연구 개발 단계Approved

IL-6 R alpha 제품 목록

  • 속성

    Protein (7)

  • 제품 라이브러리

    온라인 (7)

  • Human (4)Mouse (2)Rhesus macaque (1)

  • 태그

    His Tag (2)His Tag & Avi Tag (2)Fc Tag (2)Fc Tag & Avi Tag (1)

  • 마커

    Unconjugated (4)Biotin-labeled (3)

IL-6 R alpha분자 배경

Interleukin 6 receptor (IL6R) is also known as CD126 (Cluster of Differentiation 126) , is a potent pleiotropic cytokine that regulates cell growth and differentiation of various tissues, and is known particularly for its role in the immune response and acute phase reactions. IL6R is a protein complex consisting of a IL-6 receptor subunit (IL6R) and interleukin 6 signal transducer Glycoprotein 130. IL6R also denotes the human gene encoding this subunit. Alternatively spliced transcript variants encoding distinct isoforms have been reported. IL6R subunit also shared by many other cytokines. The soluble form of IL6R arises from proteolytic cleavage of membrane-bound IL6Rα, and acts agonistically by making the IL6 ligand accessible to the signal transducer gp130. Dysregulated production of IL6 and IL6R are implicated in the pathogenesis of several inflammatory diseases and malignancies such as multiple myeloma, rheumatoid arthritis, or osteoporosis, and it has been reported that a humanized anti-IL6R monoclonal antibody is a promising agent applicable to the therapeutic approach for IL6 driven diseases. Interleukin-6 receptor has been shown to interact with Interleukin 6 and Ciliary neurotrophic factor.

IL-6 R alpha분자 별명

IL6R,CD126,IL-6R-1,IL-6RA,IL6RA,IL-6R-alpha,IL6RQ,gp80

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
Recombinant humanized anti-IL-6R antibody (Hisun Pharma)HS-628Phase 3 ClinicalZhejiang Hisun Pharmaceutical Co LtdArthritis; Arthritis, Rheumatoid
상세
VDJ-001Phase 3 ClinicalBeijing Vdjbio Co LtdArthritis, Rheumatoid; Cardiovascular Diseases; Castleman Disease; Graves Ophthalmopathy; Multicentric Castleman's Disease (MCD); Renal Insufficiency, Chronic
상세
Tocilizumab Biosimilar (Curateq Biologics)BP08; BP-08Phase 3 ClinicalCuraTeQ Biologics Pvt LtdArthritis, Rheumatoid
상세
Tocilizumab biosimilar (GENERIUM Pharmaceuticals)GNR-087Phase 3 ClinicalGenerium PharmaceuticalsArthritis, Rheumatoid
상세
Tocilizumab biosimilar (AryoGen Pharmed)Phase 3 ClinicalAryogen BiopharmaArthritis, Rheumatoid
상세
Tocilizumab biosimilar(Hetero Biopharma)Phase 3 ClinicalHetero Biopharma LtdArthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19)
상세
LevilimabBCD-089Phase 3 ClinicalBIOCAD JSCArthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19)
상세
Atexakin alfaSON-080; r-IL-6Phase 2 ClinicalWeizmann Institute Of ScienceDiabetic Neuropathies; Peripheral Nervous System Diseases
상세
OlamkiceptFE-999301; CR-5/18; TJ-301; FE-301Phase 1 ClinicalConaris Research InstituteColitis, Ulcerative; Gastrointestinal Diseases
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
TocilizumabMRA-SC; R-1569; rhPM-1; RO-48775533; MRA; RG-1569; HPM-1ApprovedChugai Pharmaceutical Co LtdActemra, Acterma, ACTPen, RoActemra, 雅美罗JapanArthritis, RheumatoidChugai Pharmaceutical Co Ltd2005-04-11Acute Chest Syndrome; Amyotrophic Lateral Sclerosis; Anemia, Sickle Cell; Arthritis, Juvenile; Arthritis, Rheumatoid; Ascites; Behcet Syndrome; Breast Neoplasms; Carcinoma, Hepatocellular; Chondrocalcinosis; Coronary Artery Disease; Coronary Disease; Coronavirus Disease 2019 (COVID-19); Coronavirus Infections; Craniopharyngioma; Cytokine Release Syndrome; Depressive Disorder, Major; Dermatomyositis; Diabetes Mellitus; Diabetes Mellitus, Type 1; Fever; Giant Cell Arteritis; Graft vs Host Disease; Graves Ophthalmopathy; Hematologic Neoplasms; HIV Infections; Inflammation; Ischemic Stroke; Leukemia, Myeloid, Acute; Lupus Erythematosus, Systemic; Lymphoma; Motor Neuron Disease; Myocardial Infarction; Neoplasms; Non-radiographic axial spondyloarthritis; Non-ST Elevated Myocardial Infarction; Osteoarthritis; Pancreatitis, Chronic; Panuveitis; Pleural Effusion, Malignant; Pneumonia; Polyarticular Juvenile Idiopathic Arthritis; Polymyalgia Rheumatica; Polymyositis; Pulmonary Arterial Hypertension; Pulmonary Disease,
상세
Tocilizumab biosimilar (Bio-Thera Solutions)BAT-1806; BIIB-800ApprovedBio-Thera Solutions Ltd施瑞立, TOFIDENCEMainland ChinaArthritis, Rheumatoid; Arthritis, Juvenile; Cytokine Release SyndromeBio-Thera Solutions Ltd2023-01-16Arthritis, Juvenile; Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19); Cytokine Release Syndrome; Polyarticular Juvenile Idiopathic Arthritis
상세
SarilumabSAR-153191; REGN-88ApprovedRegeneron Pharmaceuticals Inc, SanofiKevzaraUnited StatesArthritis, RheumatoidSanofi-Synthelabo2017-05-22Arthritis, Juvenile; Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19); Mastocytosis, Systemic; Polyarticular Juvenile Idiopathic Arthritis; Polymyalgia Rheumatica; Sarcoidosis; Severe Acute Respiratory Syndrome; Spondylitis, Ankylosing; Uveitis
상세
Tocilizumab biosimilar (Livzon Group)LZM-008ApprovedLivzon Pharmaceutical Group Inc安维泰Mainland ChinaArthritis, RheumatoidLivzon Mabpharm Inc2023-01-18Arthritis, Rheumatoid
상세
Tocilizumab biosimilar (Fresenius kabi)MSB-11456; AT-220 (Arecor Therapeutics)ApprovedMerck SeronoTyenneEUCoronavirus Disease 2019 (COVID-19); Cytokine Release Syndrome; Arthritis, Rheumatoid; Giant Cell ArteritisFresenius Kabi Deutschland Gmbh2023-09-15Arthritis, Rheumatoid; Brain Ischemia; Coronavirus Disease 2019 (COVID-19); Cytokine Release Syndrome; Giant Cell Arteritis; Polyarticular Juvenile Idiopathic Arthritis; Subarachnoid Hemorrhage
상세
Tocilizumab biosimilar (BioRay Pharm)ApprovedHisun Biopharmaceutical Co LtdMainland ChinaArthritis, RheumatoidHisun Biopharmaceutical Co Ltd2024-06-25Arthritis, Rheumatoid
상세
Tocilizumab biosimilar (Celltrion)CT-P47; CT-P-47ApprovedCelltrion IncAvtozmaUnited StatesGiant Cell Arteritis; Polyarticular Juvenile Idiopathic Arthritis; Coronavirus Disease 2019 (COVID-19); Arthritis, Juvenile; Arthritis, RheumatoidCelltrion Inc2025-01-24Arthritis, Juvenile; Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19); Cytokine Release Syndrome; Giant Cell Arteritis; Polyarticular Juvenile Idiopathic Arthritis
상세
Tocilizumab biosimilar (Maibo Taike)CMAB-806; CMAB806ApprovedJinyu Bowo Runze Biotechnology Co Ltd, Taizhou Maibo Taike Biotechnology Co LtdMainland ChinaArthritis, RheumatoidJinyu Bowo Runze Biotechnology Co Ltd2024-10-16Arthritis; Arthritis, Rheumatoid
상세
  • 분자 정보
  • 제품 목록
  • 시판 약물 정보
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호